{
    "title": "MY BEST AND WORST INVESTMENTS: Samantha Gleave, co-manager of the Liontrust European Growth fund, on Actelion Pharmaceuticals and Opap",
    "url": "https://www.dailymail.co.uk/money/investing/article-4212860/MY-INVESTMENTS-Samantha-Gleave-Actelion-Opap.html",
    "date": "2017-02-10",
    "keywords": [
        "stock",
        "share",
        "growth",
        "fund",
        "actelion",
        "business",
        "process",
        "lottery",
        "comanager",
        "pharmaceuticalsthis",
        "firm",
        "attention",
        "cash",
        "flow",
        "company",
        "timeit",
        "pipeline",
        "development",
        "opsumit",
        "treatment",
        "blood",
        "pressurei",
        "management",
        "team",
        "stake",
        "shareholdersim",
        "person",
        "potential",
        "johnson",
        "johnsonfor",
        "portfolio",
        "price",
        "opapa",
        "operator",
        "screening",
        "lot",
        "money",
        "balance",
        "sheet",
        "dog",
        "list",
        "picker",
        "touch",
        "guide",
        "article",
        "rollout",
        "time",
        "investment",
        "thesis",
        "course",
        "crisisan",
        "antiausterity",
        "party",
        "power",
        "market",
        "companys",
        "today"
    ],
    "category": [
        "money",
        "investing"
    ]
}